SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001193125-19-266797
Filing Date
2019-10-11
Accepted
2019-10-11 16:42:07
Documents
2
Period of Report
2019-10-11

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY INFORMATION STATEMENT d726114dpre14c.htm PRE 14C 541956
2 GRAPHIC g726114dsp1.jpg GRAPHIC 9803
  Complete submission text file 0001193125-19-266797.txt   556601
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 001-38485 | Film No.: 191148464
SIC: 2834 Pharmaceutical Preparations